ACTIVE

Apotheek Heleen Mylle

Export PDF

Financial year 2025 · Closed on 30/09/2025

Net result154,6 k €+36,7 %over 1 year
Gross margin425,4 k €+15,7 %over 1 year
Equity557,1 k €-14,6 %over 1 year
Workforce1,0 ETP-16,7 %over 1 year

Identity

Source · BCE/KBO

Apotheek Heleen Mylle is a Private limited company incorporated in 2009. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Anzegem. It employs on average 1,0 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0811.322.945
Incorporation
23/04/2009
Legal form
Private limited company
Registered office
Stijn Streuvelsstraat 26
8570 Anzegem · FlandreSee on map
Contributed capital
18 600,00 €
Latest accounts
30/09/2025
Average workforce
1,0 ETP
Joint committees (1)
  • 313
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 16 filings

Trend over 16 financial years

20252024202320222021
Income statement
Gross margin425,4 k €367,6 k €276 k €312,6 k €269,1 k €
EBITDA345,5 k €282,7 k €199,1 k €249,7 k €211,8 k €
Operating result237,6 k €182,6 k €134,8 k €197,8 k €179,8 k €
Net result154,6 k €113,1 k €93,7 k €134,3 k €122,4 k €
Balance sheet
Equity557,1 k €652,4 k €539,3 k €495,6 k €411,3 k €
Total assets1,6 M €1,7 M €1,7 M €1 M €782,9 k €
Cash223,3 k €187,4 k €230,8 k €329,7 k €275,1 k €
Debts1,1 M €1 M €1,2 M €533,8 k €371,6 k €
Other
Workforce1,0 ETP1,2 ETP1,1 ETP1,0 ETP1,0 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation

Board of directors

Source · NBB, accounts to 30/09/2025

1 active · 6 ended

Active mandates

MYLLE PHARMA

Director · 0566.940.155

Represented by Heleen Mylle

Active

Ended mandates

Danielle Marien

Manager

Ended
Gerard Naessens

Manager

Ended
Heleen Mylle

Director

Ended
Heleen Mylle

Manager

Ended

Other companies at this address

Stijn Streuvelsstraat 26 8570 Anzegem
CompanyCBE no.
MYLLE PHARMA● Active
0566.940.155

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/10/202401/10/202301/10/202201/10/202101/10/202001/10/2019
Closing of the financial year30/09/202530/09/202430/09/202330/09/202230/09/202130/09/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date06/02/202617/02/202529/04/202405/04/202316/02/202218/02/2021
General meeting18/12/202514/02/202524/04/202408/03/202303/02/202201/02/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 16 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model30/09/202518/12/202506/02/2026DutchPDF
Abridged model30/09/202414/02/202517/02/2025DutchPDF
Abridged model30/09/202324/04/202429/04/2024DutchPDF
Abridged model30/09/202208/03/202305/04/2023DutchPDF
Abridged model30/09/202103/02/202216/02/2022DutchPDF
Abridged model30/09/202001/02/202118/02/2021DutchPDF
Abridged model30/09/201929/12/201927/01/2020DutchPDF
Abridged model30/09/201813/03/201914/03/2019DutchPDF
Abridged model30/09/201714/03/201830/03/2018DutchPDF
Abridged model30/09/201608/03/201710/03/2017DutchPDF
Abridged model30/09/201509/03/201631/03/2016DutchPDF
Abridged model30/09/201422/12/201423/01/2015DutchPDF
Abridged model30/09/201312/03/201429/04/2014DutchPDF
Abridged model30/09/201213/03/201330/04/2013DutchPDF
Abridged model30/09/201114/03/201226/04/2012DutchPDF
Abridged model30/09/201009/03/201129/04/2011DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 30/09/2025

1 active · 6 ended

Active mandates

MYLLE PHARMA

Director · 0566.940.155

Represented by Heleen Mylle

Active

Ended mandates

Danielle Marien

Manager

Ended
Gerard Naessens

Manager

Ended
Heleen Mylle

Director

Ended
Heleen Mylle

Manager

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates29/03/2022
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - BENAMING - DIVERSEN - DOEL - ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates18/02/2015
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other15/03/2010
    DIVERSEN
    PDF
  • Other27/04/2009
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025154,6 k €↑
  2. 2024
    Annual accounts 2024113,1 k €↑
  3. 2023
    Annual accounts 202393,7 k €↓
  4. 2022
    Annual accounts 2022134,3 k €↑
  5. 2021
    Annual accounts 2021122,4 k €↑
  6. 2020
    Annual accounts 202082,4 k €↑
  7. 2019
    Annual accounts 201979,8 k €↑
  8. 2018
    Annual accounts 201835,7 k €↑
  9. 2017
    Annual accounts 20178,9 k €↓
  10. 2016
    Annual accounts 201652,4 k €↑
  11. 2015
    Annual accounts 2015-57,9 k €↓
  12. 2014
    Annual accounts 201411,7 k €↓
  13. 2013
    Annual accounts 201370,2 k €↑
  14. 2012
    Annual accounts 201252,1 k €↑
  15. 2011
    Annual accounts 201143,8 k €↑
  16. 2010
    Annual accounts 201016,1 k €
  17. 23/04/2009
    IncorporationPrivate limited company